Partners Group to acquire majority stake in European CDMO Pharmathen
Swiss private equity firm Partners Group has agreed on behalf of its clients to acquire a majority stake in Pharmathen, a Netherlands-based pharma company, from ... Read More
Vikas Lifecare takes 22% stake in pharma manufacturer Advik Laboratories
Vikas Lifecare Limited said that it has acquired a stake of 22.04% in Advik Laboratories, a pharma manufacturing company based in New Delhi. The stake ... Read More
Lilly takes full ownership of biotech company Protomer Technologies
Eli Lilly and Company (Lilly) has taken full ownership of California-based biotech company Protomer Technologies in a deal that is potentially worth more than $1 ... Read More
Cigarette company Philip Morris to acquire British pharma company Vectura
US-based cigarette company Philip Morris International (PMI) has offered to acquire British pharma company Vectura Group plc for about £852 million ($1.2 billion) in cash, ... Read More
Danaher to acquire US CDMO Aldevron for $9.6bn
Danaher Corporation has agreed to acquire Aldevron, a North Dakota-based manufacturer of plasmid DNA, mRNA, and recombinant proteins, for nearly $9.6 billion from EQT Group’s ... Read More
AstraZeneca acquisition of Alexion comes under UK CMA’s scanner
The UK Competition and Markets Authority (CMA) has launched a phase 1 merger inquiry into $39 billion AstraZeneca’s acquisition of Alexion Pharmaceuticals, a US biopharma ... Read More
Charles River Laboratories to acquire gene therapy CDMO Vigene Biosciences
Charles River Laboratories International has signed an all-cash deal worth $292.5 million to acquire Vigene Biosciences, a US-based gene therapy contract development and manufacturing organization ... Read More
AstraZeneca shareholders approve $39bn acquisition of Alexion
AstraZeneca has secured its shareholders’ approval for its previously announced $39 billion acquisition of US biopharma company Alexion Pharmaceuticals. The pharma giant expects the acquisition ... Read More
Roivant Sciences enters into $7.3bn merger with Montes Archimedes Acquisition
Roivant Sciences has agreed to merge with Montes Archimedes Acquisition (MAAC), a Nasdaq-listed special purpose acquisition company, in a deal that values the Swiss biopharma ... Read More
MGC Pharma to acquire clinical and medical research firm MediCaNL
MGC Pharmaceuticals (MGC Pharma), a bio-pharma company focused on phytocannabinoid-derived medicines, has acquired MediCaNL, the owner of Israeli clinical and medical research company MediCaNL Israel ... Read More